Rokos Capital Management (UK)’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-24,288
Closed -$5.94M 229
2026
Q1
$5.94M Sell
24,288
-2,879
-11% -$671K 0.04% 138
2025
Q4
$5.62M Buy
+27,167
New +$5.37M 0.02% 139

Other funds holding JNJ

Rokos Capital Management (UK)'s JNJ Position: Q2 2026 in Review

Rokos Capital Management (UK) sold out of Johnson & Johnson (JNJ) in Q2 2026, closing a stake of 24,288 shares — an estimated $5.94M sold.

Rokos Capital Management (UK) first reported a position in JNJ in Q4 2025 and held it in 2 quarters. The position peaked at $5.94M in Q1 2026. 4,665 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Rokos Capital Management (UK) reported no remaining Johnson & Johnson position as of Q2 2026 after selling out during the quarter.
  • Rokos Capital Management (UK) sold 24,288 Johnson & Johnson shares in Q2 2026, an estimated $5.94M.
  • Rokos Capital Management (UK) first reported a position in Johnson & Johnson in Q4 2025 and held it in 2 quarters.
  • Rokos Capital Management (UK)'s Johnson & Johnson position peaked at $5.94M in Q1 2026.
  • 4,665 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Rokos Capital Management (UK)'s 13F filing for Q2 2026, filed 14 Aug 2026.